Key Details
Price
$5.09Annual ROE
-53.18%Beta
0.85Events Calendar
Next earnings date:
Mar 13, 2025Recent quarterly earnings:
Nov 13, 2024Recent annual earnings:
Mar 13, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
Does KORU Medical Systems Inc. (KRMD) have what it takes to be a top stock pick for momentum investors? Let's find out.
KORU Medical Systems Inc. (KRMD) came out with a quarterly loss of $0.03 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.03 per share a year ago.
KORU Medical (KRMD) announces the receipt of regulatory clearance for its FreedomEdge System in Japan.
KORU Medical Systems, Inc. (NASDAQ:KRMD) First Quarter 2024 Earnings Conference Call will be held on May 1, 2024 at 4:30 PM ET. The call will be hosted by Louisa Smith from The Gilmartin Group, with Linda Tharby, President & CEO, and Tom Adams, CFO, also participating. Other participants include analysts from Lake Street Capital Markets, Craig-Hallum, B. Riley Securities, Canaccord Genuity, and Piper Sandler. Thank you for joining the KORU Medical Systems' First Quarter 2024 Financial Results Conference Call and Webcast.
KORU Medical Systems Inc. (KRMD) reported a quarterly loss of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.04. This is an improvement from the loss of $0.05 per share reported a year ago.
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, is pleased to announce data on the impact of the Freedom Infusion System on subcutaneous immunoglobulin (SCIg) therapy for primary immunodeficiency diseases (PIDD) to be presented at the National Home Infusion Ass.
KORU Medical Systems, Inc. (KRMD) Q4 2023 Earnings Call Transcript
One key aspect of the collaboration of KORU Medical (KRMD) with a pharmaceutical manufacturer is the exploration of new therapeutic settings.
KORU Medical Systems, Inc. (NASDAQ:KRMD ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Linda Tharby - Chief Executive Officer and President, Director Tom Adams - Chief Medical Officer Conference Call Participants Caitlin Cronin - Canaccord Genuity Joseph Downing - Piper Sandler Frank Takkinen - Lake Street Capital Operator Good day. And welcome to the KORU Medical Systems Third Quarter 2023 Earnings Call.
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, is pleased to announce its participation in the Immunoglobulin National Society (“IGNS”) 2023 National Conference, taking place in Denver, Colorado from October 5th to 8th. K.
FAQ
- What is the ticker symbol for KORU Medical Systems?
- Does KORU Medical Systems pay dividends?
- What sector is KORU Medical Systems in?
- What industry is KORU Medical Systems in?
- What country is KORU Medical Systems based in?
- When did KORU Medical Systems go public?
- Is KORU Medical Systems in the S&P 500?
- Is KORU Medical Systems in the NASDAQ 100?
- Is KORU Medical Systems in the Dow Jones?
- When was KORU Medical Systems's last earnings report?
- When does KORU Medical Systems report earnings?
- Should I buy KORU Medical Systems stock now?